302 related articles for article (PubMed ID: 8446579)
1. A selective transcriptional induction system for mammalian cells based on Gal4-estrogen receptor fusion proteins.
Braselmann S; Graninger P; Busslinger M
Proc Natl Acad Sci U S A; 1993 Mar; 90(5):1657-61. PubMed ID: 8446579
[TBL] [Abstract][Full Text] [Related]
2. Yeast two-hybrid system demonstrates that estrogen receptor dimerization is ligand-dependent in vivo.
Wang H; Peters GA; Zeng X; Tang M; Ip W; Khan SA
J Biol Chem; 1995 Oct; 270(40):23322-9. PubMed ID: 7559488
[TBL] [Abstract][Full Text] [Related]
3. Cloning of the rat progesterone receptor gene 5'-region and identification of two functionally distinct promoters.
Kraus WL; Montano MM; Katzenellenbogen BS
Mol Endocrinol; 1993 Dec; 7(12):1603-16. PubMed ID: 8145766
[TBL] [Abstract][Full Text] [Related]
4. Selective interaction of hsp90 with an estrogen receptor ligand-binding domain containing a point mutation.
Aumais JP; Lee HS; Lin R; White JH
J Biol Chem; 1997 May; 272(18):12229-35. PubMed ID: 9115298
[TBL] [Abstract][Full Text] [Related]
5. Functional domains of the heavy metal-responsive transcription regulator MTF-1.
Radtke F; Georgiev O; Müller HP; Brugnera E; Schaffner W
Nucleic Acids Res; 1995 Jun; 23(12):2277-86. PubMed ID: 7610056
[TBL] [Abstract][Full Text] [Related]
6. Fusion of GAL4-VP16 to a steroid-binding domain provides a tool for gratuitous induction of galactose-responsive genes in yeast.
Louvion JF; Havaux-Copf B; Picard D
Gene; 1993 Sep; 131(1):129-34. PubMed ID: 8370533
[TBL] [Abstract][Full Text] [Related]
7. Chromatin remodeling by transcriptional activation domains in a yeast episome.
Stafford GA; Morse RH
J Biol Chem; 1997 Apr; 272(17):11526-34. PubMed ID: 9111067
[TBL] [Abstract][Full Text] [Related]
8. Mutations in the AF-2/hormone-binding domain of the chimeric activator GAL4.estrogen receptor.VP16 inhibit hormone-dependent transcriptional activation and chromatin remodeling in yeast.
Stafford GA; Morse RH
J Biol Chem; 1998 Dec; 273(51):34240-6. PubMed ID: 9852087
[TBL] [Abstract][Full Text] [Related]
9. GCN5 dependence of chromatin remodeling and transcriptional activation by the GAL4 and VP16 activation domains in budding yeast.
Stafford GA; Morse RH
Mol Cell Biol; 2001 Jul; 21(14):4568-78. PubMed ID: 11416135
[TBL] [Abstract][Full Text] [Related]
10. Generation of estrogen receptor mutants with altered ligand specificity for use in establishing a regulatable gene expression system.
Whelan J; Miller N
J Steroid Biochem Mol Biol; 1996 Apr; 58(1):3-12. PubMed ID: 8809181
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional activators differ in their responses to overexpression of TATA-box-binding protein.
Sadovsky Y; Webb P; Lopez G; Baxter JD; Fitzpatrick PM; Gizang-Ginsberg E; Cavailles V; Parker MG; Kushner PJ
Mol Cell Biol; 1995 Mar; 15(3):1554-63. PubMed ID: 7862148
[TBL] [Abstract][Full Text] [Related]
12. Activation of estrogen receptor-alpha by the heavy metal cadmium.
Stoica A; Katzenellenbogen BS; Martin MB
Mol Endocrinol; 2000 Apr; 14(4):545-53. PubMed ID: 10770491
[TBL] [Abstract][Full Text] [Related]
13. Agonist and antagonists induce homodimerization and mixed ligand heterodimerization of human progesterone receptors in vivo by a mammalian two-hybrid assay.
Leonhardt SA; Altmann M; Edwards DP
Mol Endocrinol; 1998 Dec; 12(12):1914-30. PubMed ID: 9849965
[TBL] [Abstract][Full Text] [Related]
14. Augmenting transgene expression from carcinoembryonic antigen (CEA) promoter via a GAL4 gene regulatory system.
Koch PE; Guo ZS; Kagawa S; Gu J; Roth JA; Fang B
Mol Ther; 2001 Mar; 3(3):278-83. PubMed ID: 11273768
[TBL] [Abstract][Full Text] [Related]
15. Promoter elements determining weak expression of the GAL4 regulatory gene of Saccharomyces cerevisiae.
Griggs DW; Johnston M
Mol Cell Biol; 1993 Aug; 13(8):4999-5009. PubMed ID: 8393142
[TBL] [Abstract][Full Text] [Related]
16. Strong transcriptional activators isolated from viral DNA by the 'activator trap', a novel selection system in mammalian cells.
Gstaiger M; Schaffner W
Nucleic Acids Res; 1994 Oct; 22(20):4031-8. PubMed ID: 7937127
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional activation and transformation by chimaeric Fos-estrogen receptor proteins: altered properties as a consequence of gene fusion.
Schuermann M; Hennig G; Müller R
Oncogene; 1993 Oct; 8(10):2781-90. PubMed ID: 8378087
[TBL] [Abstract][Full Text] [Related]
18. The yeast UASG is a transcriptional enhancer in human HeLa cells in the presence of the GAL4 trans-activator.
Webster N; Jin JR; Green S; Hollis M; Chambon P
Cell; 1988 Jan; 52(2):169-78. PubMed ID: 2830022
[TBL] [Abstract][Full Text] [Related]
19. Selective inhibition of activated but not basal transcription by the acidic activation domain of VP16: evidence for transcriptional adaptors.
Berger SL; Cress WD; Cress A; Triezenberg SJ; Guarente L
Cell; 1990 Jun; 61(7):1199-208. PubMed ID: 2163758
[TBL] [Abstract][Full Text] [Related]
20. Functional antagonism between the estrogen receptor and Fos in the regulation of c-fos protooncogene transcription.
Ambrosino C; Cicatiello L; Cobellis G; Addeo R; Sica V; Bresciani F; Weisz A
Mol Endocrinol; 1993 Nov; 7(11):1472-83. PubMed ID: 8114761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
